Regulatory PathRegulatory requirements compared

Active substances

Dextrose + Ringer solution

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
DEXTROSE 5% IN RINGER SOLUTION5 %Intravenous infusion · Intravenous use1 BottleSAR 11.10Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
DEXTROSE ,LACTATED RINGERS5,500 %,mlSolution for infusion · Intravenous use1 BagSAR 5.00Generic · PrescriptionQATAR PHARMAWithdrawn by regulatory authority · Not Marketed
RINGER'S & 5% DEXTROSE INJ.Solution for injection · Intravenous use1 BagSAR 5.05Generic · PrescriptionBAXTERWithdrawn by MAH · Not Marketed
RINGER'S & 5% DEXTROSE INJ.Solution for injection · Intravenous use1 BagSAR 5.05Generic · PrescriptionBAXTERWithdrawn by MAH · Not Marketed
RINGER'S & 5% DEXTROSE INJ.5,5 %,%Intravenous infusion · Intravenous use1 BottleSAR 5.00Generic · PrescriptionQATAR PHARMAWithdrawn by regulatory authority · Not Marketed
RINGERS DEXTROSE INJECTION5,5 %,%Intravenous infusion · Intravenous use1 BagSAR 5.00Generic · PrescriptionQATAR PHARMAWithdrawn by regulatory authority · Not Marketed
Indications — CHI Daman Drug Formulary

ANESTHESIA-SUPPORTIVE AGENTS/ FLUID RESUSCITATION (UNCONTROLLED BLEEDING); CENTRAL DIABETES INSIPIDUS; FLUIDS AND VOLUME EXPANDERS-MAINTENANCE FLUIDS

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.